Myositis Diagnosis and Treatment

Physical Examination Components

The American College of Physicians recommends performing manual muscle testing (MMT) of proximal, distal, and axial muscle groups bilaterally, with special attention to proximal muscles where weakness is most common 1, 2, 3
Assess for difficulty in standing up, lifting arms, and moving around, which are characteristic of inflammatory myositis 4
Distinguish true muscle weakness (characteristic of myositis) from pain-limited movement (seen in polymyalgia-like syndromes) 4

Examine for cutaneous manifestations suggestive of dermatomyositis, including Gottron papules, heliotrope rash, and shawl sign 5
Check for skin ulcerations, atrophy, or pigmentation changes that may indicate disease activity or damage 5

Measure muscle enzymes including creatine kinase (CK), aldolase, transaminases (AST/ALT), and lactate dehydrogenase (LDH) 2, 3
Check inflammatory markers (ESR, CRP) which are typically elevated in inflammatory myositis 2, 4
Consider autoantibody panels for myositis-specific antibodies (e.g., anti-TIF1γ, anti-NXP2) 2, 3

For mild disease, the American College of Rheumatology recommends initiating oral corticosteroids (prednisone 0.5 mg/kg/day) if muscle enzymes are elevated and weakness is present 2, 3
For moderate disease, the American College of Rheumatology recommends initiating prednisone 0.5-1 mg/kg/day if CK is elevated (≥3× upper limit of normal) 2, 3
For severe disease, the American College of Rheumatology recommends initiating high-dose corticosteroids (prednisone 1 mg/kg/day orally or methylprednisolone 1-2 mg/kg IV) 2, 3

Early recognition and treatment are critical to prevent irreversible muscle damage and complications, according to the American Heart Association 6
Monitor for potential cardiac involvement, which can be fatal if not detected early, as recommended by the American College of Cardiology 6
Implement physical therapy early to prevent joint contractures and muscle atrophy, as recommended by the American Physical Therapy Association 5

For mild myositis (Grade 1), primary care management with rheumatology consultation is appropriate if symptoms persist or worsen, as recommended by the American College of Rheumatology 7
For moderate myositis (Grade 2), early referral to a rheumatologist is recommended for proper diagnosis and treatment planning, according to the European Society of Medical Oncology 8, 9
For severe myositis (Grade 3-4), urgent referral to a rheumatologist is essential due to potential life-threatening complications, as stated by the American College of Rheumatology 7, 8
Neurologists may be consulted for diagnostic uncertainty between myositis and other neuromuscular disorders, or when electromyography (EMG) or nerve conduction studies are needed, as recommended by the American Academy of Neurology 7, 8
Cardiologists should be involved when there are signs of myocardial involvement, such as elevated cardiac biomarkers or abnormal ECG, according to the American Heart Association 8
A comprehensive diagnostic workup, including blood testing for muscle enzymes and autoantibody testing, should be coordinated by rheumatologists, as recommended by the American College of Rheumatology 7, 8

The American College of Cardiology recommends that cardiologists be involved in the care of patients with myositis when there are signs of cardiac involvement, such as abnormal cardiac MRI or echocardiogram 7, 8
The American Academy of Dermatology may be needed for management of skin manifestations in dermatomyositis, although specific recommendations are not provided in the cited references

For immune checkpoint inhibitor-related myositis, oncologists should work closely with rheumatologists, as recommended by the European Society of Medical Oncology 8, 10
Failing to recognize potential cardiac involvement can be fatal if not detected early, highlighting the importance of timely specialist referral, as stated by the American Heart Association 8